ahlam1399
03-29-2016, 06:42 PM
BRIEF-Biolinerx reports successful top-line phase 2 trial results
* Successful results in phase 2 trial for AML data identifya potential biomarker for future selection of BL-8040-responsiveAML patientshttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2wuJ34akAEM:RLlIhUUzEts:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2wuJ34akAEM:RLlIhUUzEts:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2wuJ34akAEM:RLlIhUUzEts:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2wuJ34akAEM:RLlIhUUzEts:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2wuJ34akAEM:RLlIhUUzEts:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/2wuJ34akAEM
* Successful results in phase 2 trial for AML data identifya potential biomarker for future selection of BL-8040-responsiveAML patientshttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2wuJ34akAEM:RLlIhUUzEts:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2wuJ34akAEM:RLlIhUUzEts:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2wuJ34akAEM:RLlIhUUzEts:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=2wuJ34akAEM:RLlIhUUzEts:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=2wuJ34akAEM:RLlIhUUzEts:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/2wuJ34akAEM